Otsuka (OTCMKTS:OTSKY) Issues Quarterly Earnings Results, Beats Expectations By $0.19 EPS

Otsuka (OTCMKTS:OTSKY) issued its quarterly earnings data on Friday. The company reported $0.70 EPS for the quarter, topping analysts’ consensus estimates of $0.51 by $0.19, Zacks reports. The firm had revenue of $4.41 billion for the quarter, compared to analyst estimates of $3.95 billion. Otsuka had a net margin of 15.01% and a return on equity of 12.33%. Otsuka updated its FY 2026 guidance to 2.119-2.119 EPS.

Otsuka Stock Down 4.0%

Shares of OTCMKTS OTSKY opened at $34.41 on Friday. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.67 and a current ratio of 2.17. Otsuka has a 1 year low of $23.67 and a 1 year high of $37.52. The stock’s 50-day simple moving average is $34.15 and its 200-day simple moving average is $33.52. The firm has a market cap of $36.96 billion and a price-to-earnings ratio of 13.82.

Otsuka Company Profile

Otsuka Pharmaceutical Co, Ltd., trading in the U.S. under the ticker OTCMKTS:OTSKY, is a global healthcare company headquartered in Tokyo, Japan. The firm’s core activities span the development, manufacturing and marketing of prescription pharmaceuticals, consumer healthcare products and nutraceuticals. Otsuka focuses its research on areas such as neuroscience, cardiovascular and renal therapies, and oncology, aiming to bring innovative treatments to patients worldwide.

Founded in 1964 by Busaburo Otsuka as a subsidiary of the Otsuka Group, the company has grown into a diversified healthcare enterprise over more than five decades.